A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
for Macular Degeneration
48 locations incl. Gilbert
Sponsor: EyeBiotech Ltd.
Sex: All·Age: 50+
Code: NCT07496567·Phase 2, Phase 3·Recruiting·Listed Mar 2026
Retina Consultants of Texas
Clinical research site in Katy, Texas · 1331 W GRAND PKWY N, STE 145, KATY, TX 77493-2717 · (866) 950-3627
Part of Retina Consultants of Texas
As of July 2026, 7 paid clinical trials are recruiting at Retina Consultants of Texas in Katy, Texas. Active studies at this site cover conditions such as Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD) and Age-Related Macular Degeneration. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Retina Consultants of Texas (7)
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
for Diabetic Macular Edema
50 locations incl. Bakersfield
Sponsor: EyePoint Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT07449936·Phase 3·Recruiting·Listed Mar 2026
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
for Age-related Macular Degeneration (AMD)
140 locations incl. Chandler
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 50 - 85
Code: NCT06541704·Phase 3·Recruiting·Listed Aug 2024
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
for Geographic Atrophy (GA)
49 locations incl. Gilbert
Sponsor: ONL Therapeutics
Sex: All·Age: 55+
Code: NCT06659445·Phase 2·Recruiting·Listed Oct 2024
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for Geographic Atrophy Secondary to Age-related Macular Degeneration
15 locations incl. Huntington Beach
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 50+
Code: NCT07441642·Phase 2·Recruiting·Listed Mar 2026
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
for Neovascular (Wet) Age-related Macular Degeneration
3 locations incl. Boston
Sponsor: Skyline Therapeutics
Sex: All·Age: 50+
Code: NCT06346600·Recruiting·Listed Apr 2024
Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
for Neovascular Age-related Macular Degeneration
4 locations incl. St. Petersburg
Sponsor: Skyline Therapeutics (US) Inc.
Sex: All·Age: 50+
Code: NCT05986864·Phase 1, Phase 2·Recruiting·Listed Aug 2023
More research sites in Katy
- Biopharma Informatic, LLC (3 trials)
- R & H Clinical Research (3 trials)
- Mt.Olympus Medical Research (2 trials)
- R and H Clinical Research (2 trials)
- Retina Consultants of Texas (Katy) (2 trials)
- Gastro Health & Nutrition (2 trials)
- 89bio Clinical Study Site (1 trial)
- Advanced Interventional Pain (1 trial)
- Artiva Investigational (1 trial)
- BRCR Global - Katy (1 trial)